MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$53.11
+5.61%
Mkt Cap $2.34B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$94.40
Range $56.00 – $150.00
Implied Upside
+77.7%
Consensus $94.40 vs current $53.11